2021
DOI: 10.3390/ijms22020911
|View full text |Cite
|
Sign up to set email alerts
|

Congenital Diseases of DNA Replication: Clinical Phenotypes and Molecular Mechanisms

Abstract: Deoxyribonucleic acid (DNA) replication can be divided into three major steps: initiation, elongation and termination. Each time a human cell divides, these steps must be reiteratively carried out. Disruption of DNA replication can lead to genomic instability, with the accumulation of point mutations or larger chromosomal anomalies such as rearrangements. While cancer is the most common class of disease associated with genomic instability, several congenital diseases with dysfunctional DNA replication give ris… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
16
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 27 publications
(16 citation statements)
references
References 211 publications
(339 reference statements)
0
16
0
Order By: Relevance
“…Because genome-instability is a hallmark of cancer, the findings described here support a previously proposed model that WASp functions within the “tumor-suppressor” apparatus in normal lymphocytes 49 , and that its loss triggers replication dysfunction and genome-instability contributing to oncogenesis in WAS. Notably, immunodeficiencies frequently occur in certain congenital diseases arising from mutations in essential replication genes 50 . In this connection, multiple WAS mutations/ variants (p.D485G; p.E486K; p.D489N; p.D493N; p.D497E; pD497Y) are reported in the public WAS-databases that occur in/or around RBM1, which could potentially disrupt RPA1-activity directly.…”
Section: Discussionmentioning
confidence: 99%
“…Because genome-instability is a hallmark of cancer, the findings described here support a previously proposed model that WASp functions within the “tumor-suppressor” apparatus in normal lymphocytes 49 , and that its loss triggers replication dysfunction and genome-instability contributing to oncogenesis in WAS. Notably, immunodeficiencies frequently occur in certain congenital diseases arising from mutations in essential replication genes 50 . In this connection, multiple WAS mutations/ variants (p.D485G; p.E486K; p.D489N; p.D493N; p.D497E; pD497Y) are reported in the public WAS-databases that occur in/or around RBM1, which could potentially disrupt RPA1-activity directly.…”
Section: Discussionmentioning
confidence: 99%
“…The region encompasses three candidate genes involved in pharyngeal arches development, including HIC2, YPEL1, and MAPK1. However, the typical auricular phenotype in these patients is preauricular tags but not microtia (Schmit & Bielinsky, 2021). One OAVS patient with central 22q11.2 deletion between LCR22B-D was reported.…”
Section: Discussionmentioning
confidence: 98%
“…The loss of cell division cycle 45 gene (CDC45, MIM *603465) embedded in 22q11.2 has been reported to be related to craniofacial malformations, as in Meier-Gorlin syndrome and craniosynostosis (Miller et al, 2017;Parker et al, 2018). As one of the components in replicative helicase Cdc45-MCM2-7-GINS (CMG), CDC45 functions in DNA replication which is crucial in many developmental processes (Schmit & Bielinsky, 2021;Tognetti et al, 2015). We therefore speculate that the loss of CDC45 on 22q11.2 is an important causal mutation for ear malformation.…”
Section: Introductionmentioning
confidence: 99%
“…Nevertheless, it is widely accepted that acquisition and sustenance of an infinite replicative potential are key factors for carcinogenesis. Retarded growth potential of human cells deficient in BLM, WRN, and RecQL4 gave a general indication that RecQ helicases participate in DNA replication [Bennett and Keck, 2004;Burla et al, 2018;Schmit and Bielinsky, 2021]. Since this review is focused on RecQL4, much of the discussion is confined only to RecQL4 and its associated activities in DNA replication.…”
Section: Sustained Proliferation Capacity In Recql4 Overexpressing Cancer Cellsmentioning
confidence: 99%